pyrrolidonecarboxylic acid has been researched along with Experimental Hepatoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elgjo, K; Endresen, L; Paulsen, JE; Reichelt, KL; Rugstad, HE; Sundby-Hall, K | 1 |
1 other study(ies) available for pyrrolidonecarboxylic acid and Experimental Hepatoma
| Article | Year |
|---|---|
The peptide pyroGlu-Gln-Gly-Ser-Asn, isolated from mouse liver, inhibits growth of rat hepatoma cells in vitro.
Topics: Amino Acid Sequence; Animals; Cell Division; DNA; Dose-Response Relationship, Drug; Liver; Liver Neoplasms, Experimental; Mice; Molecular Sequence Data; Neoplasm Transplantation; Oligopeptides; Peptides; Pyrrolidonecarboxylic Acid; Rats; Time Factors; Tumor Cells, Cultured | 1991 |